These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 31312661)
1. Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer. Zhou J; Zhao W; Wu J; Lu J; Ding Y; Wu S; Wang H; Ding D; Mo F; Zhou Z; Teng L; Chen S Biomed Res Int; 2019; 2019():8103142. PubMed ID: 31312661 [TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets. Chen C; Zhou Q; Wu R; Li B; Chen Q; Zhang X; Shi C Biomed Res Int; 2019; 2019():2183510. PubMed ID: 31781598 [TBL] [Abstract][Full Text] [Related]
3. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700 [TBL] [Abstract][Full Text] [Related]
4. Targeting Neoantigens for Personalised Immunotherapy. Pritchard AL BioDrugs; 2018 Apr; 32(2):99-109. PubMed ID: 29516371 [TBL] [Abstract][Full Text] [Related]
5. Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer. Karasaki T; Nagayama K; Kawashima M; Hiyama N; Murayama T; Kuwano H; Nitadori J; Anraku M; Sato M; Miyai M; Hosoi A; Matsushita H; Kikugawa S; Matoba R; Ohara O; Kakimi K; Nakajima J J Thorac Oncol; 2016 Mar; 11(3):324-33. PubMed ID: 26752676 [TBL] [Abstract][Full Text] [Related]
6. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies. Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747 [TBL] [Abstract][Full Text] [Related]
7. Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy? Roerden M; Nelde A; Walz JS Front Immunol; 2019; 10():3004. PubMed ID: 31921218 [TBL] [Abstract][Full Text] [Related]
8. Tumor neoantigens: building a framework for personalized cancer immunotherapy. Gubin MM; Artyomov MN; Mardis ER; Schreiber RD J Clin Invest; 2015 Sep; 125(9):3413-21. PubMed ID: 26258412 [TBL] [Abstract][Full Text] [Related]
9. [Identification of neoantigens and development of antigen-specific immunotherapy]. Shinohara S; Takahashi Y; Demachi-Okamura A; Matsushita H Rinsho Ketsueki; 2020; 61(9):1433-1439. PubMed ID: 33162546 [TBL] [Abstract][Full Text] [Related]
10. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies. Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819 [TBL] [Abstract][Full Text] [Related]
11. [Neoantigens and Whole-Exome Sequencing]. Karasaki T; Nakajima J; Kakimi K Gan To Kagaku Ryoho; 2016 Jul; 43(7):791-7. PubMed ID: 27431622 [TBL] [Abstract][Full Text] [Related]
12. Mutation-Derived Neoantigens for Cancer Immunotherapy. Castle JC; Uduman M; Pabla S; Stein RB; Buell JS Front Immunol; 2019; 10():1856. PubMed ID: 31440245 [TBL] [Abstract][Full Text] [Related]
13. Cancer Neoantigens. Schumacher TN; Scheper W; Kvistborg P Annu Rev Immunol; 2019 Apr; 37():173-200. PubMed ID: 30550719 [TBL] [Abstract][Full Text] [Related]
14. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Khodadoust MS; Olsson N; Wagar LE; Haabeth OA; Chen B; Swaminathan K; Rawson K; Liu CL; Steiner D; Lund P; Rao S; Zhang L; Marceau C; Stehr H; Newman AM; Czerwinski DK; Carlton VE; Moorhead M; Faham M; Kohrt HE; Carette J; Green MR; Davis MM; Levy R; Elias JE; Alizadeh AA Nature; 2017 Mar; 543(7647):723-727. PubMed ID: 28329770 [TBL] [Abstract][Full Text] [Related]
15. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing. Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040 [TBL] [Abstract][Full Text] [Related]
16. Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets. Chen C; Liu S; Qu R; Li B Biomed Res Int; 2020; 2020():2861240. PubMed ID: 32733937 [TBL] [Abstract][Full Text] [Related]